These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9245700)

  • 1. The angiotensin-II receptor antagonist, losartan, inhibits LDL lipid peroxidation and atherosclerosis in apolipoprotein E-deficient mice.
    Keidar S; Attias J; Smith J; Breslow JL; Hayek T
    Biochem Biophys Res Commun; 1997 Jul; 236(3):622-5. PubMed ID: 9245700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The angiotensin-converting enzyme inhibitor, fosinopril, and the angiotensin II receptor antagonist, losartan, inhibit LDL oxidation and attenuate atherosclerosis independent of lowering blood pressure in apolipoprotein E deficient mice.
    Hayek T; Attias J; Coleman R; Brodsky S; Smith J; Breslow JL; Keidar S
    Cardiovasc Res; 1999 Dec; 44(3):579-87. PubMed ID: 10690290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased plasma and lipoprotein lipid peroxidation in apo E-deficient mice.
    Hayek T; Oiknine J; Brook JG; Aviram M
    Biochem Biophys Res Commun; 1994 Jun; 201(3):1567-74. PubMed ID: 8024602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aldosterone administration to mice stimulates macrophage NADPH oxidase and increases atherosclerosis development: a possible role for angiotensin-converting enzyme and the receptors for angiotensin II and aldosterone.
    Keidar S; Kaplan M; Pavlotzky E; Coleman R; Hayek T; Hamoud S; Aviram M
    Circulation; 2004 May; 109(18):2213-20. PubMed ID: 15123520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiatherosclerotic and antioxidative effects of captopril in apolipoprotein E-deficient mice.
    Hayek T; Attias J; Smith J; Breslow JL; Keidar S
    J Cardiovasc Pharmacol; 1998 Apr; 31(4):540-4. PubMed ID: 9554802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidative stress increases the expression of the angiotensin-II receptor type 1 in mouse peritoneal macrophages.
    Keidar S; Heinrich R; Kaplan M; Aviram M
    J Renin Angiotensin Aldosterone Syst; 2002 Mar; 3(1):24-30. PubMed ID: 11984744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pomegranate phenolics from the peels, arils, and flowers are antiatherogenic: studies in vivo in atherosclerotic apolipoprotein e-deficient (E 0) mice and in vitro in cultured macrophages and lipoproteins.
    Aviram M; Volkova N; Coleman R; Dreher M; Reddy MK; Ferreira D; Rosenblat M
    J Agric Food Chem; 2008 Feb; 56(3):1148-57. PubMed ID: 18173244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antagonists of angiotensin II receptor].
    Karasek D; Adamski M; Grzeszczak W
    Postepy Hig Med Dosw; 1996; 50(1):21-32. PubMed ID: 8778711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Olmesartan, a novel angiotensin II type 1 receptor antagonist, reduces severity of atherosclerosis in apolipoprotein E deficient mice associated with reducing superoxide production.
    Shimada K; Murayama T; Yokode M; Kita T; Fujita M; Kishimoto C
    Nutr Metab Cardiovasc Dis; 2011 Sep; 21(9):672-8. PubMed ID: 20399087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Losartan inhibits cellular uptake of oxidized LDL by monocyte-macrophages from hypercholesterolemic patients.
    Hayek T; Aviram M; Heinrich R; Sakhnini E; Keidar S
    Biochem Biophys Res Commun; 2000 Jul; 273(2):417-20. PubMed ID: 10873620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of the renin-angiotensin system abolishes the proatherogenic effect of uremia in apolipoprotein E-deficient mice.
    Bro S; Binder CJ; Witztum JL; Olgaard K; Nielsen LB
    Arterioscler Thromb Vasc Biol; 2007 May; 27(5):1080-6. PubMed ID: 17347482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased low-density lipoprotein oxidation and impaired high-density lipoprotein antioxidant defense are associated with increased macrophage homing and atherosclerosis in dyslipidemic obese mice: LCAT gene transfer decreases atherosclerosis.
    Mertens A; Verhamme P; Bielicki JK; Phillips MC; Quarck R; Verreth W; Stengel D; Ninio E; Navab M; Mackness B; Mackness M; Holvoet P
    Circulation; 2003 Apr; 107(12):1640-6. PubMed ID: 12668499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic effect of losartan in a murine model of dilated cardiomyopathy: comparison with captopril.
    Kanda T; Araki M; Nakano M; Imai S; Suzuki T; Murata K; Kobayashi I
    J Pharmacol Exp Ther; 1995 May; 273(2):955-8. PubMed ID: 7752100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase.
    Aviram M; Rosenblat M; Bisgaier CL; Newton RS; Primo-Parmo SL; La Du BN
    J Clin Invest; 1998 Apr; 101(8):1581-90. PubMed ID: 9541487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attenuation of atherosclerosis in apolipoprotein E-deficient mice by ramipril is dissociated from its antihypertensive effect and from potentiation of bradykinin.
    Keidar S; Attias J; Coleman R; Wirth K; Schölkens B; Hayek T
    J Cardiovasc Pharmacol; 2000 Jan; 35(1):64-72. PubMed ID: 10630734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Losartan (Cozaar).
    Baldinger S
    Conn Med; 1996 May; 60(5):281-4. PubMed ID: 8998906
    [No Abstract]   [Full Text] [Related]  

  • 17. Impact of plasma oxidized low-density lipoprotein removal on atherosclerosis.
    Ishigaki Y; Katagiri H; Gao J; Yamada T; Imai J; Uno K; Hasegawa Y; Kaneko K; Ogihara T; Ishihara H; Sato Y; Takikawa K; Nishimichi N; Matsuda H; Sawamura T; Oka Y
    Circulation; 2008 Jul; 118(1):75-83. PubMed ID: 18559699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of angiotensin II on atherogenesis at the aortic sinus and descending aorta of apolipoprotein-E-deficient mice.
    Zhou Y; Chen R; Catanzaro SE; Hu L; Dansky HM; Catanzaro DF
    Am J Hypertens; 2005 Apr; 18(4 Pt 1):486-92. PubMed ID: 15831357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotonin derivatives, major safflower (Carthamus tinctorius L.) seed antioxidants, inhibit low-density lipoprotein (LDL) oxidation and atherosclerosis in apolipoprotein E-deficient mice.
    Koyama N; Kuribayashi K; Seki T; Kobayashi K; Furuhata Y; Suzuki K; Arisaka H; Nakano T; Amino Y; Ishii K
    J Agric Food Chem; 2006 Jul; 54(14):4970-6. PubMed ID: 16819904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new antihypertensive class: the angiotensin receptor antagonist.
    Kupecz D
    Nurse Pract; 1996 Mar; 21(3):106, 109, 113-4. PubMed ID: 8710244
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.